Gonorrhea - Pipeline Review, H2 2014

Publisher Name :
Date: 25-Oct-2014
No. of pages: 54
Inquire Before Buying

Gonorrhea - Pipeline Review, H2 2014

Summary

Global Markets Direct's, ‘Gonorrhea - Pipeline Review, H2 2014', provides an overview of the Gonorrhea's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Gonorrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gonorrhea and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Gonorrhea

- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in the therapeutics development for Gonorrhea and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Gonorrhea products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- A detailed assessment of monotherapy and combination therapy pipeline projects

- Coverage of the Gonorrhea pipeline on the basis of target, MoA, route of administration and molecule type

- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop strategic initiatives by understanding the focus areas of leading companies

- Identify and understand important and diverse types of therapeutics under development for Gonorrhea

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Devise corrective measures for pipeline projects by understanding Gonorrhea pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Gonorrhea - Pipeline Review, H2 2014

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Gonorrhea Overview 6
Therapeutics Development 7
Pipeline Products for Gonorrhea - Overview 7
Pipeline Products for Gonorrhea - Comparative Analysis 8
Gonorrhea - Therapeutics under Development by Companies 9
Gonorrhea - Pipeline Products Glance 10
Late Stage Products 10
Early Stage Products 11
Gonorrhea - Products under Development by Companies 12
Gonorrhea - Companies Involved in Therapeutics Development 13
Melinta Therapeutics, Inc 13
Cubist Pharmaceuticals, Inc. 14
PTC Therapeutics, Inc. 15
Genocea Biosciences, Inc. 16
Gonorrhea - Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Target 18
Assessment by Mechanism of Action 20
Assessment by Route of Administration 22
Assessment by Molecule Type 24
Drug Profiles 26
delafloxacin - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
solithromycin - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Gonorrhea Vaccine - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
PTC-672 - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
edodekin alfa SR - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Gonorrhea - Recent Pipeline Updates 35
Gonorrhea - Dormant Projects 46
Gonorrhea - Product Development Milestones 47
Featured News & Press Releases 47
Sep 06, 2014: Melinta Therapeutics and Hartford Hospital Demonstrate Delafloxacin's Potent In-Vitro Activity against Complicated Urinary Tract Infection Pathogens 47
Sep 06, 2014: Melinta Therapeutics and Hartford Hospital Demonstrate Delafloxacin`s Potent In-Vitro Activity against Complicated Urinary Tract Infection Pathogens 47
Sep 06, 2014: Melinta Therapeutics Reports on PK Profile of a Single Oral Dose of Delafloxacin in Support of U.S. Phase 3 Gonorrhea Program 48
Sep 04, 2014: Melinta Therapeutics Highlighting Delafloxacin and ESKAPE Candidates in Twelve Presentations at 2014 ICAAC Meeting 48
Aug 12, 2014: Cempra Initiates Phase 3 Clinical Trial in Patients With Uncomplicated Gonorrhea Infection 49
Apr 26, 2013: Cempra To Present Data On Solithromycin's Potential Against Urogenital Infections And Multidrug-Resistant Pathogens At ECCMID 50
Mar 23, 2004: IMPAX Receives Final FDA Approval for Generic Version of Declomycin; Fifth ANDA Approval in 2004 51
Appendix 53
Methodology 53
Coverage 53
Secondary Research 53
Primary Research 53
Expert Panel Validation 53
Contact Us 54
Disclaimer 54

List of Tables
Number of Products under Development for Gonorrhea, H2 2014 7
Number of Products under Development for Gonorrhea - Comparative Analysis, H2 2014 8
Number of Products under Development by Companies, H2 2014 9
Comparative Analysis by Late Stage Development, H2 2014 10
Comparative Analysis by Early Stage Development, H2 2014 11
Products under Development by Companies, H2 2014 12
Gonorrhea - Pipeline by Melinta Therapeutics, Inc, H2 2014 13
Gonorrhea - Pipeline by Cubist Pharmaceuticals, Inc., H2 2014 14
Gonorrhea - Pipeline by PTC Therapeutics, Inc., H2 2014 15
Gonorrhea - Pipeline by Genocea Biosciences, Inc., H2 2014 16
Assessment by Monotherapy Products, H2 2014 17
Number of Products by Stage and Target, H2 2014 19
Number of Products by Stage and Mechanism of Action, H2 2014 21
Number of Products by Stage and Route of Administration, H2 2014 23
Number of Products by Stage and Molecule Type, H2 2014 25
Gonorrhea Therapeutics - Recent Pipeline Updates, H2 2014 35
Gonorrhea - Dormant Projects, H2 2014 46

List of Figures
Number of Products under Development for Gonorrhea, H2 2014 7
Number of Products under Development by Companies, H2 2014 9
Comparative Analysis by Early Stage Products, H2 2014 11
Assessment by Monotherapy Products, H2 2014 17
Number of Products by Top 10 Target, H2 2014 18
Number of Products by Stage and Top 10 Target, H2 2014 19
Number of Products by Top 10 Mechanism of Action, H2 2014 20
Number of Products by Stage and Top 10 Mechanism of Action, H2 2014 21
Number of Products by Top 10 Route of Administration, H2 2014 22
Number of Products by Stage and Top 10 Route of Administration, H2 2014 23
Number of Products by Top 10 Molecule Type, H2 2014 24
Number of Products by Stage and Top 10 Molecule Type, H2 2014 25
  • Europe Peptide Therapeutics Industry 2016 Market Research Report
    Published: 24-May-2016        Price: US 3600 Onwards        Pages: 130
    The Europe Peptide Therapeutics Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Peptide Therapeutics industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Peptide Therapeutics market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status. ......
  • Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021
    Published: 12-May-2016        Price: US 4650 Onwards        Pages: 149
    The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 million by 2021 from USD 207.9 million in 2016, at a CAGR of 6.9% between 2016 and 2021. North America is expected to hold the largest share of the varicose vein treatment market in 2016. The varicose vein treatment market is broadly segmented into mode of treatment and products. By products, the varicose vein treatment market is segmented into ablation devices, venous closure products, and surgical ......
  • Global Peptide Therapeutics Pipeline Database Market Professional Survey Report 2016
    Published: 09-May-2016        Price: US 3500 Onwards        Pages: 106
    This report Mainly covers the following product types The segment applications including Segment regions including (the separated region report can also be offered) USA China Europe South America Japan Africa The players list (Partly, Players you are interested in can also be added) Novartis Pfizer Roche Sanofi Merck & Co. Johnson & Johns......
  • Global Peptide Therapeutics Consumption 2016 Market Research Report
    Published: 09-May-2016        Price: US 4000 Onwards        Pages: 170
    The Global Peptide Therapeutics Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Peptide Therapeutics market. First, the report provides a basic overview of the Peptide Therapeutics industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the glo......
  • Global Non-alcoholic Steatohepatitis Market 2016-2020
    Published: 06-May-2016        Price: US 2500 Onwards        Pages: 70
    NAFL disease, also known as fatty infiltration, is characterized by the accumulation of fat in the liver. It is of two types: NAFL and NASH. Fatty inflammation characterized by higher fat deposition than the normal level, 5%-10%, causes the disease. NASH causes severe inflammation of the liver, leading to damage of the organ. It is a benign condition of unknown etiology and is asymptomatic in nature during its initial stages, resulting in late diagnosis. Conditions such as obesity, diabetes, ......
  • Global Liver Cirrhosis Therapeutics Market 2016-2020
    Published: 06-May-2016        Price: US 2500 Onwards        Pages: 74
    Cirrhosis of the liver (or liver fibrosis) is a serious condition in which the liver stops functioning properly due to damage and irreversible scarring of the liver tissue. The scarring of the tissue is often caused by long-term exposure to viral infections and toxins such as alcohol. Chronic viral hepatitis and non-alcoholic steatohepatitis can also cause liver cirrhosis. Alcohol-related medications, antiviral medications, and metal chelating agents are used in the treatment of the causes of......
  • Global Sexual Dysfunction Partnering 2010 to 2016
    Published: 01-May-2016        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to ......
  • Global Muscular Dystrophy Partnering 2010 to 2016
    Published: 01-May-2016        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to ......
  • Global Liver Disease Partnering 2010 to 2016
    Published: 01-May-2016        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs